Loss of TRPV1-expressing sensory neurons reduces spinal μ opioid receptors but paradoxically potentiates opioid analgesia

Journal of Neurophysiology

Volumn 95, Issue 5, 2006, Pages 3086-3096

  Chen, Shao Rui ^a   Pan, Hui Lin ^a,b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE] H 3; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE 5' O (3 THIOTRIPHOSPHATE) S 35; MORPHINE; MU OPIATE RECEPTOR; RADIOLIGAND; RESINIFERATOXIN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; BRAIN NERVE CELL; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; IMMUNOREACTIVITY; MALE; NERVE CONDUCTION; NERVE ENDING; NEUROMODULATION; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORY NERVE; SENSORY NERVE CONDUCTION; SPINAL CORD; SPINAL CORD DORSAL HORN; SPINAL GANGLION;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; FLUORESCENT ANTIBODY TECHNIQUE; GANGLIA, SPINAL; GENE EXPRESSION REGULATION; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); LECTINS; MALE; MORPHINE; NEURONS, AFFERENT; PAIN MEASUREMENT; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, OPIOID, MU; SPINAL CORD; SULFUR ISOTOPES; TRITIUM; TRPV CATION CHANNELS;

EID: 33646201710     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.01343.2005     Document Type: Article

References (54)

1. Abbadie C, Lombard MC, Besson JM, Trafton JA, and Basbaum AI. Mu and delta opioid receptor-like immunoreactivity in the cervical spinal cord of the rat after dorsal rhizotomy or neonatal capsaicin: an analysis of preand postsynaptic receptor distributions. Brain Res 930: 150-162, 2002.
2. Averill S, McMahon SB, Clary DO, Reichardt LF, and Priestley JV. Immunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neurons. Eur J Neurosci 7: 1484-1494, 1995.
3. Bennett DL, Michael GJ, Ramachandran N, Munson JB, Averill S, Yan Q, McMahon SB, and Priestley JV. A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J Neurosci 18: 3059-3072, 1998.
4. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, and Lin FT. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286: 2495-2498, 1999.
5. Burgess PR and Perl ER. Myelinated afferent fibres responding specifically to noxious stimulation of the skin. J Physiol 190: 541-562, 1967.
6. Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, and Julius D. Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288: 306-313, 2000.
7. Chen SR and Pan HL. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats. Anesthesiology 99: 1409-1414, 2003a.
8. Chen SR and Pan HL. Up-regulation of spinal muscarinic receptors and increased antinociceptive effect of intrathecal muscarine in diabetic rats. J Pharmacol Exp Ther 307: 676-681, 2003b.
9. Chen SR, Sweigart KL, Lakoski JM, and Pan HL. Functional mu opioid receptors are reduced in the spinal cord dorsal horn of diabetic rats. Anesthesiology 97: 1602-1608, 2002.
10. Chen YP, Chen SR, and Pan HL. Effect of morphine on deep dorsal horn projection neurons depends on spinal GABAergic and glycinergic tone: implications for reduced opioid effect in neuropathic pain. J Pharmacol Exp Ther 315: 696-703, 2005.
11. Crowley C, Spencer SD, Nishimura MC, Chen KS, Pitts-Meek S, Armanini MP, Ling LH, MacMahon SB, Shelton DL, Levinson AD, and Phillips HS. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76: 1001-1011, 1994.
12. Dickenson AH. Spinal cord pharmacology of pain. Br J Anaesth 75: 193-200, 1995.
13. Doly S, Fischer J, and Conrath M. The vanilloid receptor-1 (TRPV1) is expressed in some rat dorsal horn NK1 cells. Brain Res 1004: 203-207, 2004.
14. Einarsdottir E, Carlsson A, Minde J, Toolanen G, Svensson O, Solders G, Holmgren G, Holmberg D, and Holmberg M. A mutation in the nerve growth factor beta gene (NGFB) causes loss of pain perception. Hum Mol Genet 13: 799-805, 2004.
15. Fields HL, Emson PC, Leigh BK, Gilbert RF, and Iversen LL. Multiple opiate receptor sites on primary afferent fibres. Nature 284: 351-353, 1980.
16. Gamse R, Holzer P, and Lembeck F. Indirect evidence for presynaptic location of opiate receptors on chemosensitive primary sensory neurons. Naunyn Schmiedebergs Arch Pharmacol 308: 281-285, 1979.
17. Guo A, Vulchanova L, Wang J, Li X, and Elde R. Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neurosci 11: 946-958, 1999.
18. Harper AA and Lawson SN. Conduction velocity is related to morphological cell type in rat dorsal root ganglion neurons. J Physiol 359: 31-46, 1985.
19. Jancso G and Jancso-Gabor A. Effect of capsaicin on morphine analgesia-possible involvement of hypothalamic structures. Naunyn Schmiedebergs Arch Pharmacol 311: 285-288, 1980.
20. Johnson EM Jr, Gorin PD, Brandeis LD, and Pearson J. Dorsal root ganglion neurons are destroyed by exposure in utero to maternal antibody to nerve growth factor. Science 210: 916-918, 1980.
21. Karai L, Brown DC, Mannes AJ, Connelly ST, Brown J, Gandal M, Wellisch OM, Neubert JK, Olah Z, and Iadarola MJ. Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control. J Clin Invest 113: 1344-1352, 2004.
22. King AP, Hall KE, and Macdonald RL. kappa- and mu-Opioid inhibition of N-type calcium currents is attenuated by 4beta-phorbol 12-myristate 13-acetate and protein kinase C in rat dorsal root ganglion neurons. J Pharmacol Exp Ther 289: 312-320, 1999.
23. Kitchener PD, Lapiz MD, Wilson P, and Snow PJ. Transganglionic labelling of primary sensory afferents in the rat lumbar spinal cord: comparison between wheatgerm agglutinin and the I-B4 isolectin from Bandeiraea simplicifolia. J Neurocytol 23: 745-757, 1994.
24. Kitchener PD, Wilson P, and Snow PJ. Selective labelling of primary sensory afferent terminals in lamina II of the dorsal horn by injection of Bandeiraea simplicifolia isolectin B4 into peripheral nerves. Neuroscience 54: 545-551, 1993.
25. Kohno T, Kumamoto E, Higashi H, Shimoji K, and Yoshimura M. Actions of opioids on excitatory and inhibitory transmission in substantia gelatinosa of adult rat spinal cord. J Physiol 518: 803-813, 1999.
26. Lewinter RD, Skinner K, Julius D, and Basbaum AI. Immunoreactive TRPV-2 (VRL-1), a capsaicin receptor homolog, in the spinal cord of the rat. J Comp Neurol 470: 400-408, 2004.
27. Light AR and Willcockson HH. Spinal laminae I-II neurons in rat recorded in vivo in whole cell, tight seal configuration: properties and opioid responses. J Neurophysiol 82: 3316-3326, 1999.
28. Magnuson DS and Dickenson AH. Lamina-specific effects of morphine and naloxone in dorsal horn of rat spinal cord in vitro. J Neurophysiol 66: 1941-1950, 1991.
29. Mardy S, Miura Y, Endo F, Matsuda I, and Indo Y. Congenital insensitivity to pain with anhidrosis (CIPA): effect of TRKA (NTRK1) missense mutations on autophosphorylation of the receptor tyrosine kinase for nerve growth factor. Hum Mol Genet 10: 179-188, 2001.
30. McMahon SB, Armanini MP, Ling LH, and Phillips HS. Expression and coexpression of Trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron 12: 1161-1171, 1994.
31. Mestek A, Hurley JH, Bye LS, Campbell AD, Chen Y, Tian M, Liu J, Schulman H, and Yu L. The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J Neurosci 15: 2396-2406, 1995.
32. Molliver DC, Radeke MJ, Feinstein SC, and Snider WD. Presence or absence of TrkA protein distinguishes subsets of small sensory neurons with unique cytochemical characteristics and dorsal horn projections. J Comp Neurol 361: 404-416, 1995.
33. Narita M, Mizoguchi H, Suzuki T, Dun NJ, Imai S, Yajima Y, Nagase H, and Tseng LF. Enhanced mu-opioid responses in the spinal cord of mice lacking protein kinase Cgamma isoform. J Biol Chem 276: 15409-15414, 2001.
34. Olah Z, Szabo T, Karai L, Hough C, Fields RD, Caudle RM, Blumberg PM, and Iadarola MJ. Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J Biol Chem 276: 11021-11030, 2001.
35. Pan HL, Khan GM, Alloway KD, and Chen SR. Resiniferatoxin induces paradoxical changes in thermal and mechanical sensitivities in rats: mechanism of action. J Neurosci 23: 2911-2919, 2003.
36. Saeki S and Yaksh TL. Suppression of nociceptive responses by spinal mu opioid agonists: effects of stimulus intensity and agonist efficacy. Anesth Analg 77: 265-274, 1993.
37. Sastry BR and Goh JW. Actions of morphine and met-enkephalin-amide on nociceptor driven neurons in substantia gelatinosa and deeper dorsal horn. Neuropharmacology 22: 119-122, 1983.
38. Schneider SP, Eckert WA, 3rd, and Light AR. Opioid-activated postsynaptic, inward rectifying potassium currents in whole cell recordings in substantia gelatinosa neurons. J Neurophysiol 80: 2954-2962, 1998.
39. Schulz R, Wehmeyer A, and Schulz K. Opioid receptor types selectively cointernalize with G protein-coupled receptor kinases 2 and 3. J Pharmacol Exp Ther 300: 376-384, 2002.
40. Slugg RM, Meyer RA, and Campbell JN. Response of cutaneous A- and C-fiber nociceptors in the monkey to controlled-force stimuli. J Neurophysiol 83: 2179-2191, 2000.
41. Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, Lira SA, and Barbacid M. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368: 246-249, 1994.
42. Snider WD and McMahon SB. Tackling pain at the source: new ideas about nociceptors. Neuron 20: 629-632, 1998.
43. Szallasi A and Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 51: 159-212, 1999.
44. Szallasi A, Blumberg PM, Annicelli LL, Krause JE, and Cortright DN. The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons. Mol Pharmacol 56: 581-587, 1999.
45. Tamura S, Morikawa Y, and Senba E. TRPV2, a capsaicin receptor homologue, is expressed predominantly in the neurotrophin-3-dependent subpopulation of primary sensory neurons. Neuroscience 130: 223-228, 2005.
46. Valtschanoff JG, Rustioni A, Guo A, and Hwang SJ. Vanilloid receptor VR1 is both presynaptic and postsynaptic in the superficial laminae of the rat dorsal horn. J Comp Neurol 436: 225-235, 2001.
47. Wang H, Rivero-Melian C, Robertson B, and Grant G. Transganglionic transport and binding of the isolectin B4 from Griffonia simplicifolia I in rat primary sensory neurons. Neuroscience 62: 539-551, 1994.
48. Whistler JL and von Zastrow M. Morphine-activated opioid receptors elude desensitization by beta-arrestin. Proc Natl Acad Sci USA 95: 9914-9919, 1998.
49. Woolf CJ and Fitzgerald M. Lamina-specific alteration of C-fibre evoked activity by morphine in the dorsal horn of the rat spinal cord. Neurosci Lett 25: 37-41, 1981.
50. 2+ channel currents to a mu opioid in isolectin B4-positive and -negative dorsal root ganglion neurons. J Pharmacol Exp Ther 311: 939-947, 2004.
51. Wu ZZ, Chen SR, and Pan HL. Transient receptor potential vanilloid type 1 activation down-regulates voltage-gated calcium channels through calcium-dependent calcineurin in sensory neurons. J Biol Chem 280: 18142-18151, 2005.
52. Xu XJ, Farkas-Szallasi T, Lundberg JM, Hokfelt T, Wiesenfeld-Hallin Z, and Szallasi A. Effects of the capsaicin analogue resiniferatoxin on spinal nociceptive mechanisms in the rat: behavioral, electrophysiological and in situ hybridization studies. Brain Res 752: 52-60, 1997.
53. Yaksh TL and Noueihed R. The physiology and pharmacology of spinal opiates. Annu Rev Pharmacol Toxicol 25: 433-462, 1985.
54. Yoshimura M and North RA. Substantia gelatinosa neurones hyperpolarized in vitro by enkephalin. Nature 305: 529-530, 1983.